Researchers Discover New Antibody Treatment To Protect Against Marburg Virus

The antibodies target a new site on Marburg virus that protects against the virus up to 90 to 100 percent, which could lead to treatments for Marburg and Ebola virus.

A new antibody treatment that protect against the deadly Marburg virus, has been identified by a team of scientists at The Scripps Research Institute (TSRI).

"These antibodies attack a new site on Marburg virus we had not seen before," said Erica Ollmann Saphire, senior author of the new study, professor at TSRI and director of the Viral Hemorrhagic Fever Immunotherapeutic Consortium.

Growth Pattern of Marburg Virus in Cells Discovered by Mount Sinai Scientists
A protein that interacts with Marburg virus VP24 and allows the deadly virus to live longer and replicate better is the one that normally protects cells from environmental stress, find researchers.

Currently there are no vaccines for Marburg infections, which has a mortality rate up to 90 percent. The new antibodies identify and neutralize Marburg virus.

The new study found a molecular structure that Marburg virus uses to attach to enter host cells.

TSRI, Mapp Biopharmaceutical, Biotherapeutics and BioSolutions collaborated in an academic-industrial partnership to conduct the study.

Five Ugandans in Isolation After Marburg Virus Death
Ugandan health officials are continuing to monitor five people feared to have contracted the Ebola-like Marburg virus, even though all suspected cases so far have tested negative.

The new antibodies target a new site on Marburg virus, which was not seen before - a wing-like feature attached to the base of the virus.

The new antibodies protected 90 to 100 percent of the infected animal models from the deadly disease. Researchers said that some antibodies can also cross-react with Ebola virus.

Human Antibodies can Neutralize the Marburg Virus, a Close Cousin to Ebola Virus
A new study has revealed that human antibodies can neutralize the Marburg virus, a close cousin to Ebola virus.

Marnie Fusco, TSRI Research Assistant and first author of the study, said, “We expect both Marburg virus and Ebola virus to emerge again and to acquire new mutations. The cross-reactive antibodies could be used as diagnostics for newly emerging strains.”

Source-Medindia

No Fresh Cases of Ebola-Like Marburg Virus: Uganda
All suspected cases of the Ebola-like Marburg virus had tested negative and those held in isolation released, say Ugandan health officials.